Zoetis Inc (ZTS)

165.02 +1.53 (+0.94%) USD  |  NYSE  |  Jan 08, 16:00
165.00 -0.02 (-0.01%) Pre-Market: 04:41
More

Zoetis SG&A Expense (Quarterly): 565.00M for Sept. 30, 2024

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for ZTS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense Definition

View SG&A Expense Definition
Start Trial

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Vertex Pharmaceuticals Inc 371.80M
Alnylam Pharmaceuticals Inc 220.99M
Biomarin Pharmaceutical Inc 253.50M
Corcept Therapeutics Inc 73.74M
Plus Therapeutics Inc 2.397M